正文共2000字 2图预计阅读时间5分钟在2025年5月22日,全球医药巨头赛诺菲(Sanofi)宣布了一项重要决定:以每股8美元现金的价格,总额约4.7亿美元收购Vigil Neuroscience。这一价格显著高于Vigil Neuroscience目前1.15亿美元的市值,溢价高达246%。这次收购的核心在于VG-3927,一种针对骨髓细胞表达触发受体2(TREM2)的口服小分子激动剂,用于...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.